Objective The ability to recognize molecular processes using novel imaging techniques is of fundamental importance for medicine, biology and biochemistry in the 21st century. Non-invasive molecular imaging has gained widespread use in patient management of cancer, life-science and medical research, as well as drug discovery and development. The capability of non-invasive metabolic profiling is expected to impact dramatically patient management for socioeconomically relevant diseases. Spatially-resolved observation of metabolites will be key for enabling more accurate staging of diseases by direct assessment of the underlying impact on the metabolism. Quantification of, for example, the perturbation of the myocardial, tumor, or neural substrate metabolism will most likely revolutionize staging and management of diseases in cardiology, neurology, oncology and other fields. Building on novel quantum technology using nitrogen-vacancy in diamonds we have developed in first in the DIAMANT FET project, and continued the FET proactive project DIADEMS - DIAmond Devices Enabled Metrology and Sensing, we are developing an MRI-based breakthrough technology for enabling previously unachievable, highly sensitive quantification of metabolic imaging, enabling earlier diagnostic and personalized therapies, thus substantially improving patient management. However, research and development are not sufficient for attracting private investors and commercialization of a disruptive technology. In QUSMI we will understand the customer needs, reach out to strategic partners, consolidate our IP portfolio and strategy, and develop our business plan. Thus placing us in a position to attract private investors and commercialize the research technology into a product. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverymedical and health sciencesclinical medicineoncologyprostate cancermedical and health scienceshealth sciencespersonalized medicineengineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imagingmedical and health sciencesbasic medicineneurology Programme(s) H2020-EU.1.2. - EXCELLENT SCIENCE - Future and Emerging Technologies (FET) Main Programme H2020-EU.1.2.1. - FET Open Topic(s) FETOPEN-04-2016-2017 - FET Innovation Launchpad Call for proposal H2020-FETOPEN-2016-2017 See other projects for this call Sub call H2020-FETOPEN-4-2016-2017 Funding Scheme CSA - Coordination and support action Coordinator NVISION IMAGING TECHNOLOGIES GMBH Net EU contribution € 77 562,30 Address WOLFGANG-PAUL-STRASSE 2 89081 ULM Germany See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Baden-Württemberg Tübingen Ulm, Stadtkreis Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 77 562,50 Participants (1) Sort alphabetically Sort by Net EU contribution Expand all Collapse all UNIVERSITAET ULM Germany Net EU contribution € 18 900,00 Address HELMHOLTZSTRASSE 16 89081 Ulm See on map Region Baden-Württemberg Tübingen Ulm, Stadtkreis Activity type Higher or Secondary Education Establishments Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 18 900,00
